Matches in Wikidata for { <http://www.wikidata.org/entity/Q56957641> ?p ?o ?g. }
- Q56957641 description "article publié dans la revue scientifique The Lancet" @default.
- Q56957641 description "artículu científicu" @default.
- Q56957641 description "im Juni 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q56957641 description "scientific article published in The Lancet" @default.
- Q56957641 description "wetenschappelijk artikel" @default.
- Q56957641 description "наукова стаття, опублікована в червні 2018" @default.
- Q56957641 description "ശാസ്ത്രപ്രബന്ധം" @default.
- Q56957641 name "Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial" @default.
- Q56957641 name "Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial" @default.
- Q56957641 type Item @default.
- Q56957641 label "Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial" @default.
- Q56957641 label "Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial" @default.
- Q56957641 prefLabel "Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial" @default.
- Q56957641 prefLabel "Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial" @default.
- Q56957641 P1433 Q56957641-5B7EB534-B601-45B9-B194-357D1E9BFF29 @default.
- Q56957641 P1476 Q56957641-CB9A5FA1-9DA1-4A65-95AB-E1EDE7C98AA4 @default.
- Q56957641 P2093 Q56957641-46C886BC-EC82-485B-8517-231BB97044E3 @default.
- Q56957641 P2093 Q56957641-A45D821E-5309-425A-8CE1-81EF6E46AB8F @default.
- Q56957641 P2093 Q56957641-B15D9160-68AF-4DB1-BEAC-54762F50715A @default.
- Q56957641 P2093 Q56957641-C5B050E5-47F2-4E8E-A50F-6F9AC85B45E4 @default.
- Q56957641 P2093 Q56957641-FA9C11D4-3B40-4C75-AEAB-2BE54F223A20 @default.
- Q56957641 P2860 Q56957641-08BF9B39-948C-4663-B295-F3C11D0FB212 @default.
- Q56957641 P2860 Q56957641-16B39E56-E5C6-4DAF-817B-C07D8D8072FE @default.
- Q56957641 P2860 Q56957641-1E628A12-9F75-499C-AB36-F3A60DC60A01 @default.
- Q56957641 P2860 Q56957641-23A3C69C-AC3B-4D34-8438-14B15D3F6F0B @default.
- Q56957641 P2860 Q56957641-2AFCFD27-1EA6-47DA-AB0C-0C64BA752F34 @default.
- Q56957641 P2860 Q56957641-39CDF4EB-4668-457A-8F31-81E1FD5539AD @default.
- Q56957641 P2860 Q56957641-3A2D1860-D101-4D90-B60B-56C93F476BCD @default.
- Q56957641 P2860 Q56957641-44462980-3DEA-473E-AA45-B92AE3447E78 @default.
- Q56957641 P2860 Q56957641-49CB8C3A-5995-4E51-9573-66779F296728 @default.
- Q56957641 P2860 Q56957641-4BC5098E-505D-4FCD-9503-C1016E90DDA0 @default.
- Q56957641 P2860 Q56957641-56EF9101-7B81-4F1F-874D-FD23123610CF @default.
- Q56957641 P2860 Q56957641-5C9AB980-B532-4CF9-8D21-6A56BB26A679 @default.
- Q56957641 P2860 Q56957641-6CA783B8-2D48-46A1-9541-07466109B7E8 @default.
- Q56957641 P2860 Q56957641-81FA4C33-E149-4F03-8CFB-72DE3BE38603 @default.
- Q56957641 P2860 Q56957641-92D62A19-E051-41A2-A4C7-5733C7EB62D5 @default.
- Q56957641 P2860 Q56957641-95E82371-F144-463B-AE95-4766A2DD544C @default.
- Q56957641 P2860 Q56957641-9D10E600-9FCC-4F6E-8A6F-4D33C1D4C337 @default.
- Q56957641 P2860 Q56957641-9FCDAD09-18D9-48A2-9339-005AD3270192 @default.
- Q56957641 P2860 Q56957641-A83C82C0-07C3-4A48-BB30-2D102559E992 @default.
- Q56957641 P2860 Q56957641-B95BEE7A-2B07-4A8E-A70E-30FBBF0182F2 @default.
- Q56957641 P2860 Q56957641-C8F2A872-6249-429E-BD0F-B40F8F0F9EFD @default.
- Q56957641 P2860 Q56957641-D50F3137-DB9D-4A73-8B07-0A277BB2440A @default.
- Q56957641 P2860 Q56957641-D8B001CA-1FA4-4CAC-A8CD-0BBAEE14CCBA @default.
- Q56957641 P2860 Q56957641-E1F26B64-E532-4447-9592-CCF5B571B806 @default.
- Q56957641 P2860 Q56957641-EC3EFE7C-CA92-41BC-9BBF-14DFD0FAFFEE @default.
- Q56957641 P2860 Q56957641-FDC960BA-310F-4070-9B86-229FB7E2BAF6 @default.
- Q56957641 P2860 Q56957641-FF9B23D1-3BB2-4093-8E6A-F56623439CF5 @default.
- Q56957641 P304 Q56957641-828D7AE1-8D56-47C0-94E6-E9CA31759D64 @default.
- Q56957641 P31 Q56957641-A850A8E0-1CD8-42C0-B56A-7AA2DB1FDAA5 @default.
- Q56957641 P356 Q56957641-C0092830-293C-4451-83D2-427516C3FF88 @default.
- Q56957641 P407 Q56957641-BA1023A8-47A5-4C4B-8B7A-8517AA67B109 @default.
- Q56957641 P433 Q56957641-559A84C8-C29F-4BBC-B1D5-4424F0930C62 @default.
- Q56957641 P478 Q56957641-04A54467-0A7E-4674-A1DE-3DB542BACAE1 @default.
- Q56957641 P50 Q56957641-1F0F0025-C418-4108-B5BC-BB641271F178 @default.
- Q56957641 P50 Q56957641-320050D5-E3ED-4654-B499-F8956A5839CD @default.
- Q56957641 P50 Q56957641-4C748FFF-2250-4CF8-B5B8-DAF620515A78 @default.
- Q56957641 P50 Q56957641-51BDCEE3-8A57-44F1-A2F7-DF6492F1FBC7 @default.
- Q56957641 P50 Q56957641-76E7B79E-7F3F-46B4-A4E6-251AAD8B3D41 @default.
- Q56957641 P50 Q56957641-E8F7A996-B517-471F-AC0A-43D9E6D201AC @default.
- Q56957641 P577 Q56957641-4A41D18B-E208-406C-B67D-E4CAB9FAC0DE @default.
- Q56957641 P698 Q56957641-B1708911-810A-433C-9ADB-FA086D23BA9C @default.
- Q56957641 P921 Q56957641-0811B012-019F-4546-8C72-E36B367EECD6 @default.
- Q56957641 P921 Q56957641-16FC817E-F062-4B19-87A0-1D9CE5B1EE04 @default.
- Q56957641 P921 Q56957641-E69C8105-2E53-4B43-853A-42DA8955B765 @default.
- Q56957641 P356 S0140-6736(18)31115-2 @default.
- Q56957641 P698 29908669 @default.
- Q56957641 P1433 Q939416 @default.
- Q56957641 P1476 "Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial" @default.
- Q56957641 P2093 "Filip Van den Bosch" @default.
- Q56957641 P2093 "Gerd R Burmester" @default.
- Q56957641 P2093 "Joel M Kremer" @default.
- Q56957641 P2093 "Yihan Li" @default.
- Q56957641 P2093 "Yijie Zhou" @default.
- Q56957641 P2860 Q31158500 @default.
- Q56957641 P2860 Q34130671 @default.
- Q56957641 P2860 Q34264322 @default.
- Q56957641 P2860 Q34269994 @default.
- Q56957641 P2860 Q34500921 @default.
- Q56957641 P2860 Q34533371 @default.
- Q56957641 P2860 Q34533379 @default.
- Q56957641 P2860 Q37604501 @default.
- Q56957641 P2860 Q38065765 @default.
- Q56957641 P2860 Q38317993 @default.
- Q56957641 P2860 Q38476881 @default.
- Q56957641 P2860 Q39124523 @default.
- Q56957641 P2860 Q39371685 @default.
- Q56957641 P2860 Q39588332 @default.
- Q56957641 P2860 Q40305889 @default.
- Q56957641 P2860 Q40735626 @default.
- Q56957641 P2860 Q43869407 @default.
- Q56957641 P2860 Q45842857 @default.
- Q56957641 P2860 Q47643186 @default.
- Q56957641 P2860 Q48679388 @default.
- Q56957641 P2860 Q50094018 @default.
- Q56957641 P2860 Q54114604 @default.
- Q56957641 P2860 Q60061984 @default.
- Q56957641 P2860 Q63101754 @default.
- Q56957641 P2860 Q81377140 @default.
- Q56957641 P2860 Q84141779 @default.